Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

INTERVIEW: EU industry calls for specialized, not special, notified bodies

This article was originally published in Clinica

Executive Summary

The EU medtech industry is calling for notified bodies who audit innovative and high-risk devices to specialize in specific medical domains, a measure that goes beyond what have been proposed so far by either the European Commission or Parliament. This specialization would address the demands of a sector that spans a wide range of technologies used in a broad scope of medical applications and carry a variety of potential risks.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT101608

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel